Do you want to read an article? Please log in or register.
COVID-19 Associated Thrombosis and Coagulopathy: Review of the Pathophysiology and Implications for Antithrombotic Management
Thrombosis and Stroke
Related content
Thrombosis and Stroke
Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review
JAMA Cardiol
Rizk JG, Gupta A, Sardar P, Henry BM, Lewin JC, Lippi G, Lavie CJ
doi: 10.1001/jamacardio.2021.3444
Heart Failure
Management of Heart Failure Patients with COVID-19. A Joint Position Paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology
Eur J Heart Fail.
Zhang Y, Stewart Coats AJ, Zheng Z, Adamo M, Ambrosio G, Anker SD, Butler J, Xu D, Mao J, Khan MS, Bai L, Mebazaa A, Ponikowski P, Tang Q, Ruschitzka F, Seferovic P, Tschöpe C, Zhang S, Gao C, Zhou S, Senni M, Zhang J, Metra M
doi: 10.1002/ejhf.1915.
RECOMMENDED
Cardiovascular Risk and Diseases
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Eur Heart J
Task Force for the management of COVID-19 of the European Society of Cardiology .
doi: 10.1093/eurheartj/ehab696
Thrombosis and Stroke
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
J Am Coll Cardiol.
Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, Nigoghossian C, Ageno W, Madjid M, Guo Y, Tang LV, Hu Y, Giri J, Cushman M, Quéré I, Dimakakos EP, Gibson CM, Lippi G, Favaloro EJ, Fareed J, Caprini JA, Tafur AJ, Burton JR, Francese DP, Wang EY, Falanga A, McLintock C, Hunt BJ, Spyropoulos AC, Barnes GD, Eikelboom JW, Weinberg I, Schulman S, Carrier M, Piazza G, Beckman JA, Steg PG, Stone GW, Rosenkranz S, Goldhaber SZ, Parikh SA, Monreal M, Krumholz HM, Konstantinides SV, Weitz JI, Lip GYH
doi: 10.1016/j.jacc.2020.04.031.
RECOMMENDED
Cardiovascular Risk and Diseases
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Eur Heart J
Task Force for the management of COVID-19 of the European Society of Cardiology .
doi: 10.1093/eurheartj/ehab697
Cardiovascular Risk and Diseases
Association of Kidney Disease With Outcomes in COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry
J Am Heart Assoc
Rao A, Ranka S, Ayers C, Hendren N, Rosenblatt A, Alger HM, Rutan C, Omar W, Khera R, Gupta K, Mody P, DeFilippi C, Das SR, Hedayati SS, de Lemos JA
doi: 10.1161/JAHA.121.020910
Further Publications
The American Heart Association COVID-19 CVD Registry powered by Get With The Guidelines®
Circ Cardiovasc Qual Outcomes.
Alger HM, Rutan C, Williams Iv JH, Walchok JG, Bolles M, Hall JL, Bradley SM, Elkind MSV, Rodriguez F, Wang TY, Morrow DA, Das SR, de Lemos JA
doi: 10.1161/CIRCOUTCOMES.120.006967.
Heart, Artery and Coronary Diseases
Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management
Heart Rhythm.
Siripanthong B, Nazarian S, Muser D, Deo R, Santangeli P, Khanji MY, Cooper LT Jr, Chahal CAA
doi: 10.1016/j.hrthm.2020.05.001.
Further Publications
The Science Underlying COVID-19: Implications for the Cardiovascular System
Circulation.
Liu PP, Blet A, Smyth D, Li H
doi: 10.1161/CIRCULATIONAHA.